Lipaglyn Tablet is a prescription medication containing the active ingredient saroglitazar, designed to help individuals with type 2 diabetes who also struggle with high levels of fats in their blood, such as triglycerides and cholesterol. This drug stands out because it addresses both blood sugar control and lipid imbalances at the same time, making it a useful option when standard treatments like statins fall short. Developed in India and approved there for specific uses, it's particularly aimed at reducing the risks associated with diabetic dyslipidemia, a condition where diabetes leads to unhealthy fat profiles that can heighten heart disease chances. It's not a replacement for lifestyle changes like diet and exercise but works alongside them to improve overall metabolic health.

Composition:

Each uncoated tablet contains Saroglitazar 4 mg and Excipients q.s.

Uses & Benefits of Lipaglyn Tablet:

This tablet is mainly prescribed for lowering elevated triglycerides and managing dyslipidemia in people with type 2 diabetes, especially those whose conditions aren't fully controlled by other medications. It can also support better blood sugar management by reducing long-term glucose markers like HbA1c and may assist in handling non-alcoholic fatty liver disease, where excess fat accumulates in the liver without alcohol involvement. Among its key advantages are its ability to decrease harmful fats while boosting beneficial cholesterol, potentially leading to modest weight reduction of about 1.5 to 3 kilograms over several months in some users. Overall, it offers a combined approach to tackling diabetes-related fat issues, which might lower the likelihood of cardiovascular complications and enhance liver function in affected individuals.

Lipaglyn Tablet is a prescription medication containing the active ingredient saroglitazar, designed to help individuals with type 2 diabetes who also struggle with high levels of fats in their blood, such as triglycerides and cholesterol. This drug stands out because it addresses both blood sugar control and lipid imbalances at the same time, making it a useful option when standard treatments like statins fall short. Developed in India and approved there for specific uses, it's particularly aimed at reducing the risks associated with diabetic dyslipidemia, a condition where diabetes leads to unhealthy fat profiles that can heighten heart disease chances. It's not a replacement for lifestyle changes like diet and exercise but works alongside them to improve overall metabolic health.

Composition:

Each uncoated tablet contains Saroglitazar 4 mg and Excipients q.s.

Uses & Benefits of Lipaglyn Tablet:

This tablet is mainly prescribed for lowering elevated triglycerides and managing dyslipidemia in people with type 2 diabetes, especially those whose conditions aren't fully controlled by other medications. It can also support better blood sugar management by reducing long-term glucose markers like HbA1c and may assist in handling non-alcoholic fatty liver disease, where excess fat accumulates in the liver without alcohol involvement. Among its key advantages are its ability to decrease harmful fats while boosting beneficial cholesterol, potentially leading to modest weight reduction of about 1.5 to 3 kilograms over several months in some users. Overall, it offers a combined approach to tackling diabetes-related fat issues, which might lower the likelihood of cardiovascular complications and enhance liver function in affected individuals.

While many tolerate Lipaglyn well, possible reactions include feeling fatigued, mild fever, stomach discomfort such as nausea or bloating, lightheadedness, chest tightness, or minor swelling in limbs. These are often temporary and mild, but rarer issues like muscle aches or allergic responses like skin rashes warrant immediate medical advice to rule out anything serious.

Store below 25°C and in dry place. Protect from light.

Keep out of reach of children.

Discard any altered or expired doses properly.